Maixin Bio is a developer of tumor immunohistochemical diagnostic reagents, covering four fields: tumor pathological diagnosis, immunocytochemical diagnosis, molecular pathological diagnosis and precise medical diagnosis. Committed to the development, production and sale of a variety of ready-to-use antibodies and concentrated antibodies for immunohistochemical tumor diagnosis and research, immunology and molecular pathology reagents and their auxiliary products, acting as agents for thousands of antibodies and supporting reagents.
More peer analysis, the company knows and understands.